Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients

Power Life Sciences

Status: Not yet enrolling

Conditions: Chronic Lymphocytic Leukemia

Study type: Observational

Funder types: Industry

Identifiers

NCT05899543

83115421

Details and patient eligibility

About

This research study aims to address the limited understanding of the challenges faced by specific demographic groups of chronic lymphocytic leukemia patients in their participation in clinical trials.

This trial will scrutinize the experiences of patients diagnosed with chronic lymphocytic leukemia as they take part in a separate medical intervention clinical trial. The focus will be on tracking the rates of completion and withdrawal among these individuals.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future chronic lymphocytic leukemia patients.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient has been diagnosed with chronic lymphocytic leukemia
• Patient is a minimum of 18 years or older
• Able to comprehend the investigational nature of the protocol and provide informed consent

Exclusion criteria

• Pregnant or lactating women
• Patients who are currently receiving any other investigational drug
• Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial

Trial design